These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25675122)

  • 21. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
    Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
    World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
    Kassouf W; Svatek RS; Shariat SF; Novara G; Lerner SP; Fradet Y; Bastian PJ; Aprikian A; Karakiewicz PI; Fritsche HM; Dinney CP; Tilki D; Kamat AM; Izawa JI; Ficarra V; Lotan Y; Sagalowsky AI; Schoenberg MP; Skinner EC
    Urol Oncol; 2013 May; 31(4):480-6. PubMed ID: 21478035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed.
    Jeong IG; Park J; Song K; Ro JY; Song C; Hong JH; Ahn H; Kim CS
    Urol Oncol; 2011; 29(2):199-204. PubMed ID: 19556153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection.
    Dhar NB; Campbell SC; Zippe CD; Derweesh IH; Reuther AM; Fergany A; Klein EA
    BJU Int; 2006 Dec; 98(6):1172-5. PubMed ID: 16956353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.
    May M; Herrmann E; Bolenz C; Brookman-May S; Tiemann A; Moritz R; Fritsche HM; Burger M; Trojan L; Michel MS; Wülfing C; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Bastian PJ
    Ann Surg Oncol; 2011 Jul; 18(7):2018-25. PubMed ID: 21246405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologic outcome after laparoscopic radical cystectomy without neoadjuvant or adjuvant therapy with a median follow-up of 32 months.
    Hermans TJ; Fossion LM
    Urol Int; 2014; 92(1):55-63. PubMed ID: 24061529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.
    May M; Herrmann E; Bolenz C; Tiemann A; Brookman-May S; Fritsche HM; Burger M; Buchner A; Gratzke C; Wülfing C; Trojan L; Ellinger J; Tilki D; Gilfrich C; Höfner T; Roigas J; Zacharias M; Gunia S; Wieland WF; Hohenfellner M; Michel MS; Haferkamp A; Müller SC; Stief CG; Bastian PJ
    Eur Urol; 2011 May; 59(5):712-8. PubMed ID: 21296488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.
    Fleischmann A; Thalmann GN; Markwalder R; Studer UE
    J Clin Oncol; 2005 Apr; 23(10):2358-65. PubMed ID: 15800327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery.
    Jensen JB; Ulhøi BP; Jensen KM
    BJU Int; 2010 Jul; 106(2):199-205. PubMed ID: 20002670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy.
    Cha EK; Sfakianos JP; Sukhu R; Yee AM; Sjoberg DD; Bochner BH
    BJU Int; 2018 Oct; 122(4):627-632. PubMed ID: 29633530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of the number of retreived lymph nodes during cystectomy.
    Karadeniz T; Baran C; Topsakal M; Kavukcu E
    Urol J; 2011; 8(3):197-202. PubMed ID: 21910098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome.
    Frank I; Cheville JC; Blute ML; Lohse CM; Nehra A; Weaver AL; Karnes RJ; Zincke H
    Cancer; 2003 May; 97(10):2425-31. PubMed ID: 12733141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.
    Soave A; Dahlem R; Hansen J; Weisbach L; Minner S; Engel O; Kluth LA; Chun FK; Shariat SF; Fisch M; Rink M
    Eur J Surg Oncol; 2015 Mar; 41(3):368-77. PubMed ID: 24674298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.
    Bochner BH; Cho D; Herr HW; Donat M; Kattan MW; Dalbagni G
    J Urol; 2004 Oct; 172(4 Pt 1):1286-90. PubMed ID: 15371825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.
    Fritsche HM; May M; Denzinger S; Otto W; Siegert S; Giedl C; Giedl J; Eder F; Agaimy A; Novotny V; Wirth M; Stief C; Brookman-May S; Hofstädter F; Gierth M; Aziz A; Kocot A; Riedmiller H; Bastian PJ; Toma M; Wieland WF; Hartmann A; Burger M
    Eur Urol; 2013 Apr; 63(4):739-44. PubMed ID: 23079053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
    Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G
    BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone.
    Mertens LS; Meijer RP; Meinhardt W; van der Poel HG; Bex A; Kerst JM; van der Heijden MS; Bergman AM; Horenblas S; van Rhijn BW
    BJU Int; 2014 Jul; 114(1):67-74. PubMed ID: 24053889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
    Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M
    Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer.
    Moschini M; Arbelaez E; Cornelius J; Mattei A; Shariat SF; Dell Oglio P; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
    Urol Oncol; 2018 Jun; 36(6):307.e9-307.e14. PubMed ID: 29602638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.